Patents by Inventor Narendra Dhanraj Lalwanl

Narendra Dhanraj Lalwanl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210322375
    Abstract: Disclosed herein are compositions comprising fixed doses of ETC-1002 and Ezetimibe. Also disclosed herein are methods for using fixed doses of ETC-1002 and Ezetimibe. Uses include methods of treating cardiovascular disease or reducing the risk of cardiovascular disease in a subject. Uses also include methods of treating hypercholesterolemia in a subject.
    Type: Application
    Filed: August 26, 2019
    Publication date: October 21, 2021
    Inventors: Diane Elaine MacDougall, Narendra Dhanraj Lalwanl